A glycosylated type I membrane protein becomes cytosolic when peptide:: N-glycanase is compromised

被引:105
作者
Blom, D [1 ]
Hirsch, C [1 ]
Stern, P [1 ]
Tortorella, D [1 ]
Ploegh, HL [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
glycoprotein turnover; HCMV; peptide : N-glycanase; siRNA; US2;
D O I
10.1038/sj.emboj.7600090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytomegalovirus-encoded glycoprotein US2 catalyzes proteasomal degradation of Class I major histocompatibility complex (MHC) heavy chains (HCs) through dislocation of the latter from the endoplasmic reticulum ( ER) to the cytosol. During this process, the Class I MHC HCs are deglycosylated by an N-glycanase-type activity. siRNA molecules designed to inhibit the expression of the light chain, beta(2)-microglobulin, block the dislocation of Class I MHC molecules, which implies that US2-dependent dislocation utilizes correctly folded Class I MHC molecules as a substrate. Here we demonstrate it is peptide: N-glycanase ( PNGase or PNG1) that deglycosylates dislocated Class I MHC HCs. Reduction of PNGase activity by siRNA expression in US2-expressing cells inhibits deglycosylation of Class I MHC HC molecules. In PNGase siRNA-treated cells, glycosylated HCs appear in the cytosol, providing the first evidence for the presence of an intact N-linked type I membrane glycoprotein in the cytosol. N-glycanase activity is therefore not required for dislocation of glycosylated Class I MHC molecules from the ER.
引用
收藏
页码:650 / 658
页数:9
相关论文
共 55 条
  • [1] The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61β and a cytosolic, deglycosylated intermediary
    Bebök, Z
    Mazzochi, C
    King, SA
    Hong, JS
    Sorscher, EJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) : 29873 - 29878
  • [2] Architecture of the protein-conducting channel associated with the translating 80S ribosome
    Beckmann, R
    Spahn, CMT
    Eswar, N
    Helmers, J
    Penczek, PA
    Sali, A
    Frank, J
    Blobel, G
    [J]. CELL, 2001, 107 (03) : 361 - 372
  • [3] Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors
    Bogyo, M
    McMaster, JS
    Gaczynska, M
    Tortorella, D
    Goldberg, AL
    Ploegh, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6629 - 6634
  • [4] CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS
    BRODSKY, FM
    BODMER, WF
    PARHAM, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) : 536 - 545
  • [5] Stable suppression of tumorigenicity by virus-mediated RNA interference
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. CANCER CELL, 2002, 2 (03) : 243 - 247
  • [6] The dolichol pathway of N-linked glycosylation
    Burda, P
    Aebi, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1426 (02): : 239 - 257
  • [7] CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
  • [8] Quality control in the endoplasmic reticulum
    Ellgaard, L
    Helenius, A
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (03) : 181 - 191
  • [9] ER quality control: towards an understanding at the molecular level
    Ellgaard, L
    Helenius, A
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (04) : 431 - 437
  • [10] Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein
    Fiebiger, E
    Story, C
    Ploegh, HL
    Tortorella, D
    [J]. EMBO JOURNAL, 2002, 21 (05) : 1041 - 1053